ELAP Services competitors

David Schandel is a Board Member at Florida Health Care Plans, CFO/Assoc CEO/Treasurer/Secy at Florida Health Care Plans, and Vice President at Florida Health Care Plans. He has experience at Ernst & Ernst and Deloitte. David attended University of Central Florida.

Chief Operating Officer of Northern California-based Sutter Health, a not-for-profit health system caring for nearly 3 million patients-or one in every 100 Americans. Oversees operations across Sutter Health’s 24 hospitals and 5 medical foundations. Also deeply committed to working with the community to help solve some of our most challenging issues. I’m energized and grateful for the opportunity to help lead businesses, private philanthropists and elected officials in three counties to adopt a common housing-first framework with the goal of reaching functional zero for homelessness. I am on the Board of the CaIifornia Business Roundtable and the Greater Sacramento Area Economic Council. A strong, vibrant community with sufficient employment and advancement opportunities allows people to live more fulfilling, healthier lives.

Norma Diaz is a Chief Executive Officer at Community Health Group and is based in Greater San Diego Area.

Jake Orville has 20+ years of diagnostic, life science and medical device management experience within both established and emerging markets. As the General Manager of Pipeline at Exact Sciences, Jake leads the company's efforts to develop and advance solutions for earlier detection and life changing answers across the cancer continuum. Prior to Exact Sciences, Jake co-founded Cleveland HeartLab, Inc. (CHL) and served as the CEO from inception to exit. CHL was spun-out of the Cleveland Clinic to develop and rapidly commercialize unique diagnostic technologies, with applications in cardiovascular and inflammatory indications. CHL was acquired by Quest Diagnostics in December 2017. Jake Served as the General Manager of the Cardiometabolic & Endocrinology Franchise at Quest. Under Jake’s leadership, CHL was recognized as Ohio’s Venture of the Year (2012); received an Economic Impact Award by the city of Cleveland for job creation (2013) and was recognized as an Inc. 500 fastest growing private company in the US (2014). Jake has been recognized as a Top 50 Smart Leader by Smart Magazine and received the Annual Innovation Award in 2018 Prior to co-founding Cleveland HeartLab, Jake was CEO of Prognostix and held Senior Management positions with two publically traded companies (NextGen Sciences - AIM NGG.L; Third Wave Technologies - Nasdaq TWTI). He is a co-founder of Viridian Medical and Tolera Therapeutics and currently sits on the Board of Directors for The Wisconsin Women’s Health Foundation. Jake has raised capital from multiple sources, including top tier venture funds, strategic and international investors as well as angels, family offices and state funding sources. A well recognized entrepreneur, he has given many lectures on innovation, commercialization, early stage ventures, technology transfer and intellectual property. Jake received his Bachelor of Arts from the University of Massachusetts, Amherst and his MBA from the University of Wisconsin, Madison.